A trial in which AAV2 gene therapy was used to treat PD delivered the human aromatic L-amino acid decarboxylase (AADC) enzyme through magnetic resonance imaging (MRI)-guided adenoviral vector delivery. Here, DDC is linked to Parkinson disease.